Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets: 2023-2025

  • Zhengye Biotechnology Holding's Other Non-Current Assets was N/A to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year change of. This contributed to the annual value of $2.6 million for FY2024, which is 178.38% up from last year.
  • According to the latest figures from Q2 2025, Zhengye Biotechnology Holding's Other Non-Current Assets is $2.3 million, which was down 8.38% from $2.6 million recorded in Q4 2024.
  • Zhengye Biotechnology Holding's Other Non-Current Assets' 5-year high stood at $2.6 million during Q4 2024, with a 5-year trough of $903,324 in Q4 2023.
  • For the 3-year period, Zhengye Biotechnology Holding's Other Non-Current Assets averaged around $1.9 million, with its median value being $2.3 million (2025).
  • Data for Zhengye Biotechnology Holding's Other Non-Current Assets shows a peak YoY surged of 183.62% (in 2024) over the last 5 years.
  • Over the past 3 years, Zhengye Biotechnology Holding's Other Non-Current Assets (Quarterly) stood at $903,324 in 2023, then spiked by 183.62% to $2.6 million in 2024, then reached $2.3 million in 2025.
  • Its Other Non-Current Assets stands at $2.3 million for Q2 2025, versus $2.6 million for Q4 2024 and $903,324 for Q4 2023.